Howard Gurney is the Director of Medical Oncology and Clinical Research at Macquarie University Hospital. He is a Clinical Associate Professor at both Macquarie University and University of Sydney. He also is a medical oncologist at Westmead Hospital. Professor Gurney has a firm background in clinical research and has subspecialty interests in lymphoma and uro-genital cancers including prostate, bladder, testis and kidney cancer.

He has been principle investigator for over 150 phase 2 and 3 clinical studies. Current research interests include the pharmacogenomics and therapeutic monitoring of chemotherapy and targeted therapies and he has published widely in this area. He is regarded as a world authority on mechanisms for safe dosing of anticancer agents and has written a number of invited editorials on this topic for the Lancet Oncology and the Journal of Clinical Oncology.

Professor Richard Kefford (RK) was Founding Director of the Department of Medical Oncology at Westmead Hospital in 1986, the Familial Cancer Service at Westmead in 1992 and the Westmead Institute for Cancer Research (WICR) in 1996. WICR was one of three institutes that united to form the Westmead Millennium Institute in 1999, and RK was founding Deputy Director 1999-2013. He was a founding Member of Melanoma Institute Australia and Co-Director of Research since its inception. He was University of Sydney Professor of Medicine at Westmead Hospital 1998-2013. Since 2014, as Head of Clinical Medicine, he is playing an instrumental role in many aspects of MQ Health.

Professor Georgina Long

Speciality: Medical Oncology

Suite 5 & 6, Melanoma Institute Australia

Wollstonecraft, NSW, 2065

Phone: 02 9911 7210 Fax: 02 9954 9290

.

Dr Pirooz Poursoltan

Speciality: Medical Oncology

Team: Breast Oncology, Colorectal Oncology, Lung Oncology

Macquarie University Clinic Suite 302, Level 3

2 Technology Place , Macquarie University, NSW, 2109

Phone: 02 9887 8899 Fax: 02 9887 8800 Email: ccc@muh.org.au

Dr Poursoltan is a medical oncologist with a special interest in gastro-intestinal, lung and breast cancers. He worked at Royal North Shore Hospital and has been practising at Macquarie University Hospital since 2011. Dr Poursoltan holds a Master of Science in Medicine from The University of Sydney. He has also taken extra training in genetics with interest in Molecular biology of lung cancer, during which he worked on the genes potentially involved in the pathogenesis of lung cancer. Dr Poursoltan has worked at the Garvan Institute and University of Sydney.